Credit Suisse’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-44,800
| Closed | -$1.23M | – | 3423 |
|
|
2022
Q4 | $1.23M | Sell |
44,800
-8,172
| -15% | -$224K | ﹤0.01% | 2182 |
|
|
2022
Q3 | $1.27M | Sell |
52,972
-7,731
| -13% | -$186K | ﹤0.01% | 2133 |
|
|
2022
Q2 | $1.6M | Sell |
60,703
-694
| -1% | -$18.3K | ﹤0.01% | 2046 |
|
|
2022
Q1 | $1.63M | Sell |
61,397
-657
| -1% | -$17.5K | ﹤0.01% | 2205 |
|
|
2021
Q4 | $1.68M | Sell |
62,054
-62
| -0.1% | -$1.68K | ﹤0.01% | 2254 |
|
|
2021
Q3 | $1.59M | Buy |
62,116
+2,354
| +4% | +$60.2K | ﹤0.01% | 2298 |
|
|
2021
Q2 | $1.55M | Buy |
59,762
+9,762
| +20% | +$253K | ﹤0.01% | 2342 |
|
|
2021
Q1 | $1.28M | Hold |
50,000
| – | – | ﹤0.01% | 2428 |
|
|
2020
Q4 | $1.29M | Sell |
50,000
-426
| -0.8% | -$11K | ﹤0.01% | 2403 |
|
|
2020
Q3 | $1.21M | Buy |
+50,426
| New | +$1.21M | ﹤0.01% | 2143 |
|